The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

European Pharmaceutical Review (Dec, 2021): CDDF Article

European Pharmaceutical Review (Dec, 2021): CDDF Article

Jan 11, 2022 | CDDF News

The CDDF’s article on “United efforts to accelerate drug development” has been published in the European Pharmaceutical Review (Dec, 2021). In the article, Prof. John Smyth (Chairman), Prof. Axel Glasmacher (Treasurer) and Prof. Jaap Verweij...
Happy Christmas!

Happy Christmas!

Dec 20, 2021 | CDDF News

The CDDF team wishes you a happy holiday season! Thank you for your continued support and collaboration in 2021.
CDDF 12th Spring Conference meeting report is now available!

CDDF 12th Spring Conference meeting report is now available!

Mar 30, 2021 | CDDF News

The CDDF 12th Spring Conference took place on 8-10 February 2021, virtually. This multi-stakeholder, interactive meeting offered plenary lectures with moderated discussions, including case studies as well as networking opportunities. The programme focused on the...
NEW CDDF INDUSTRY PARTNER – Varian Medical Systems

NEW CDDF INDUSTRY PARTNER – Varian Medical Systems

Feb 23, 2021 | CDDF News

Varian Medical Systems becomes first medical technology company to join The Cancer Drug Development Forum (CDDF). We welcome Varian to the CDDF Industry Partners Platform and look forward to great collaboration in 2021! To read...

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70